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In a recent study, Professor Rui-Ping Xiao and her research 
group at Institute of Molecular Medicine of Peking Univer-
sity has provided an essential experimental evidence to 
support the new paradigm of functional selectivity for G 
protein-coupled receptor (GPCR) signal transduction. The 
study was published online on May 15 in The Journal of 
Biological Chemistry [1].  
The GPCR superfamily, a class of membrane proteins 
responsible for transmembrane signal transduction, has been 
a focal point in the field of biomedical research as well as 
drug discovery and development. Drugs targeting this su-
perfamily account for about 50% of all prescription phar-
maceuticals on the market. Recently, a paradigm called 
functional selectivity of GPCR signaling has been proposed 
to explain how different ligands can cause a single GPCR to 
relay diverse downstream signals. According to this para-
digm, ligand-specific receptor signaling (biased signaling) 
depends on ligand-specific receptor conformation.  How-
ever, this understanding suffers from the lack of struc-
ture-function-based experimental evidence. 
As early as 2003 [2], Rui-Ping Xiao and her team dis-
covered that while most 2-adrenergic receptor (2-AR) 
agonists stimulate the receptor to activate both the stimula-
tory G proteins (Gs) and the inhibitory G proteins (Gi) to 
produce dual signaling, fenoterol stimulates the Gs-selective 
2-AR signaling, but the molecular mechanism for the func-
tional selectivity of 2-AR signaling remains elusive. 
The latest study by Woo et al. [1] demonstrated that “ty-
rosine 308 is necessary for Gs-biased signaling of β2-AR”. 
The researchers found that (R,R′)-4′-aminofenoterol, an  
analog of fenoterol, stimulates the wild-type β2-AR to pro-
duce selectively Gs signaling but stimulates the β2-AR 
Y308F mutant to produce Gs and Gi dual signaling.  Fur-
ther application of a cohort of fenoterol derivatives in com-
puter modeling studies and biological assays on cardiomy-
ocytes led to the identification of a hydrogen bond interac-
tion between the 4′-O or 4′-N of the ligand and the phenyl 
hydroxyl group of β2-AR-Y308 necessary for Gs-biased 
signaling (Figure 1). 
The study reported for the first time the identification of 
a ligand-receptor interaction dedicated to functional selec-
tivity. It also revealed the structural basis of functional se-
lectivity for 2-AR signaling and provided structural in-
sights for structure-based design of signaling pathway-   
specific drugs. 
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Figure 1  Schematic diagrams of different conformations and signalings in 2-AR and 2-AR Y308F mutant. Molecular model of 2-AR (pdb:2RH1) em-
bedded in lipid bilayer depicting Y308 on transmembrane helix (TM) 7 near the extracellular surface (top panel). Extracellular views of the wild-type (WT) 
2-AR (bottom left panel) and the 2-AR Y308F mutant (bottom right panel). Only TMs 3, 5, 6 and 7 are shown since they form the ligand binding pockets 
of 2-AR. (R,R′)-4′-Aminofenoterol (schematic structure with 2 Rs and 2 benzenes) is positioned in each of the ligand binding pockets of the WT and Y308F 
receptors based on molecular modeling data. Small red dots represent hydroxyl groups while small blue dots represent amino groups. Orange dotted circles 
represent the positions of TMs 5, 6 and 7 relative to TM 3 of the 2-ARs in the inverse agonist-bound conformation. Solid circles represent the positions of 
the TMs in functionally selective conformations. The tentative positions of TMs 6 and 7 in functionally selective conformation of the WT 2-AR are addi-
tionally shown as black dotted circles in the bottom right panel. Studies has shown that the movement of TM 6 at the cytoplasmic end is the greatest among 
the TMs during 2-AR activation and has a direct effect on Gs protein coupling although the movement at the ligand binding region is very subtle. A hydro-
gen bond interaction between the 4′-amino group of the ligand and the phenyl hydroxyl group of Y308 is depicted as a green line in the WT 2-AR model 
(bottom left). This hydrogen bond interaction is absent in the corresponding 2-AR Y308F mutant model (bottom right). It is postulated that the Gs-biased 
2-AR agonist (R,R′)-4′-aminofenoterol interacts specifically via a hydrogen bond with 2-AR-Y308 and results in a receptor conformation that selectively 
activates Gs signaling. In contrast, due to the absence of the key hydrogen bond, the Gs-baised agonist induces a different receptor conformation (particularly 
the change in TM 6 position) in the 2-AR Y308F mutant. The result is the activation of promiscuous Gs and Gi dual signaling. The TMs of 2-AR, ligand 
molecules and their positions are not drawn to scales. The functionally selective conformations shown in the diagram are not necessarily equivalent to active 
conformations. Rather, they should be more appropriately understood as intermediate states during ligand binding-induced conformational transition. 
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